FXIa-IN-13

• UNSPSC Description:

  FXIa-IN-13 (example 1) is an Factor Xa inhibitor with antithrombotic activity. FXIa-IN-13 inhibits arteriovenous thrombosis in vivo and in vitro[1].

• Target Antigen:

  Factor Xa

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/fxia-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C(C=C1)=C(C(C(OC)=NN2[C@H](C(NC(C=C3)=CC=C3C(O)=O)=O)CC4=CC=CC=C4)=CC2=O)C=C1Cl)=O

• Molecular Weight:

  545.97

• References & Citations:

  [1]Xiao Ying, et al. Pharmaceutical use of fxia inhibitor compound or salt thereof. World Intellectual Property Organization, WO2022083707 A1. 2022-04-28.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2629361-99-3